CDKN1B and cancer: Additionally, miR-221 directly downregulates critical cell-cycle inhibitors such as CDKN1B (p27^Kip1^) and CDKN1C (p57^Kip2^), contributing to unchecked cellular proliferation across several cancer types [21].